BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16002749)

  • 1. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease.
    Lawrie A; Spiekerkoetter E; Martinez EC; Ambartsumian N; Sheward WJ; MacLean MR; Harmar AJ; Schmidt AM; Lukanidin E; Rabinovitch M
    Circ Res; 2005 Aug; 97(3):227-35. PubMed ID: 16002749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.
    Liu Y; Suzuki YJ; Day RM; Fanburg BL
    Circ Res; 2004 Sep; 95(6):579-86. PubMed ID: 15297378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4.
    Spiekerkoetter E; Guignabert C; de Jesus Perez V; Alastalo TP; Powers JM; Wang L; Lawrie A; Ambartsumian N; Schmidt AM; Berryman M; Ashley RH; Rabinovitch M
    Circ Res; 2009 Sep; 105(7):639-47, 13 p following 647. PubMed ID: 19713532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1/2 and PDK through 5-HT1B receptors and 5-HT transporters.
    Liu Y; Tian HY; Yan XL; Fan FL; Wang WP; Han JL; Zhang JB; Ma Q; Meng Y; Wei F
    Cardiovasc Pathol; 2013; 22(6):451-7. PubMed ID: 23601559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy.
    Greenway S; van Suylen RJ; Du Marchie Sarvaas G; Kwan E; Ambartsumian N; Lukanidin E; Rabinovitch M
    Am J Pathol; 2004 Jan; 164(1):253-62. PubMed ID: 14695338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of S100A4/Mts1 and associated proteins in the protective effect of fluoxetine against MCT - Induced pulmonary hypertension in rats.
    Song ZH; Wang HM; Liu M; Bai Y; Wang Y; Wang HL
    J Chin Med Assoc; 2018 Dec; 81(12):1077-1087. PubMed ID: 30031694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.
    Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR
    Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serotonin receptor and transporter as potential therapeutic targets for pulmonary hypertension.
    Wang HL
    Curr Opin Investig Drugs; 2004 Sep; 5(9):963-6. PubMed ID: 15503652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.
    Eddahibi S; Fabre V; Boni C; Martres MP; Raffestin B; Hamon M; Adnot S
    Circ Res; 1999 Feb; 84(3):329-36. PubMed ID: 10024307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.
    Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S
    Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
    Liu Y; Fanburg BL
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of gammaHV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin.
    Spiekerkoetter E; Alvira CM; Kim YM; Bruneau A; Pricola KL; Wang L; Ambartsumian N; Rabinovitch M
    Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L276-89. PubMed ID: 18083765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells.
    Liu Y; Li M; Warburton RR; Hill NS; Fanburg BL
    FASEB J; 2007 Sep; 21(11):2725-34. PubMed ID: 17504974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension.
    Merklinger SL; Wagner RA; Spiekerkoetter E; Hinek A; Knutsen RH; Kabir MG; Desai K; Hacker S; Wang L; Cann GM; Ambartsumian NS; Lukanidin E; Bernstein D; Husain M; Mecham RP; Starcher B; Yanagisawa H; Rabinovitch M
    Circ Res; 2005 Sep; 97(6):596-604. PubMed ID: 16109920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway.
    Han X; Chen C; Cheng G; Liang L; Yao X; Yang G; You P; Shou X
    Microvasc Res; 2015 Jul; 100():17-24. PubMed ID: 25937083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts.
    Mair KM; MacLean MR; Morecroft I; Dempsie Y; Palmer TM
    Br J Pharmacol; 2008 Oct; 155(4):606-16. PubMed ID: 18695640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular S100A4 induces smooth muscle cell phenotypic transition mediated by RAGE.
    Chaabane C; Heizmann CW; Bochaton-Piallat ML
    Biochim Biophys Acta; 2015 Sep; 1853(9):2144-57. PubMed ID: 25110349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kappaB and V(D)J recombination signal sequence binding protein KRC regulates transcription of the mouse metastasis-associated gene S100A4/mts1.
    Hjelmsoe I; Allen CE; Cohn MA; Tulchinsky EM; Wu LC
    J Biol Chem; 2000 Jan; 275(2):913-20. PubMed ID: 10625627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.
    Morecroft I; Loughlin L; Nilsen M; Colston J; Dempsie Y; Sheward J; Harmar A; MacLean MR
    J Pharmacol Exp Ther; 2005 May; 313(2):539-48. PubMed ID: 15659538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.
    Tajeddinn W; Persson T; Calvo-Garrido J; Seed Ahmed M; Maioli S; Vijayaraghavan S; Kazokoglu MS; Parrado-Fernández C; Yoshitake T; Kehr J; Francis P; Winblad B; Höglund K; Cedazo-Minguez A; Aarsland D
    J Alzheimers Dis; 2016 May; 53(1):349-61. PubMed ID: 27163814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.